RT Journal Article
SR Electronic
T1 Effective design of barrier enclosure to contain aerosol emissions from COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.22.20246868
DO 10.1101/2020.12.22.20246868
A1 Dan Daniel
A1 Marcus Lin
A1 Irvan Luhung
A1 Tony Lui
A1 Anton Sadovoy
A1 Xueqi Koh
A1 Anqi Sng
A1 Tuan Tran
A1 Stephan C. Schuster
A1 Xian Jun Loh
A1 Oo Schwe Thet
A1 Chee Keat Tan
YR 2021
UL http://medrxiv.org/content/early/2021/04/16/2020.12.22.20246868.abstract
AB Facing shortages of personal protective equipment, some clinicians have advocated the use of barrier enclosures (typically mounted over the head, with and without suction) to contain aerosol emissions from coronavirus disease 2019 (COVID-19) patients. There is however little evidence for its usefulness. To test the effectiveness of such a device, we built a manikin that can expire micron-sized aerosols at flow rates close to physiological conditions. We then placed the manikin inside the enclosure and used a laser sheet to visualize the aerosol leaking out. We show that with sufficient suction, it is possible to effectively contain aerosol from the manikin even at high flow rates (up to 60 L min−1) of oxygen, reducing aerosol exposure outside the enclosure by 99%. In contrast, a passive barrier without suction only reduces aerosol exposure by 60%.Competing Interest StatementNgee Ann Polytechnic and Ng Teng Fong general Hospital have filed a patent submission for the barrier enclosure design.Funding StatementWe are grateful to the Agency for Science, Technology and Research for providing financial support under A*CRUSE funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB exemptAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon reasonable request.